Renaissance Technologies - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$959
-51.8%
51,300
-52.7%
0.00%
-66.7%
Q1 2023$1,991
+211.1%
108,500
+235.9%
0.00%
+200.0%
Q4 2022$640
-99.9%
32,300
+8.8%
0.00%0.0%
Q3 2022$715,000
-28.6%
29,700
-34.7%
0.00%0.0%
Q1 2022$1,001,000
+44.2%
45,500
+140.7%
0.00%0.0%
Q4 2021$694,000
-41.5%
18,900
-50.5%
0.00%
-50.0%
Q3 2021$1,186,000
+441.6%
38,200
+244.1%
0.00%
Q4 2020$219,00011,1000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders